Moderna Announces the U.S. Food and Drug Administration will Initiate the Review of Its Investigational Seasonal Influenza Vaccine Submission
Original source ↗  |  February 18, 2026 at 12:00 UTC  |  Finnhub - MRNA

No analysis available.

Trade Ideas
Ticker Direction Speaker Thesis Time
MRNA
NONE Finnhub News — —